Vaccine hesitancy in people with multiple sclerosis
Mult Scler Relat Disord
.
2022 Sep:65:104102.
doi: 10.1016/j.msard.2022.104102.
Epub 2022 Aug 10.
Authors
Jeannette S Lechner-Scott
1
,
Joshua S Davis
2
,
Christopher Hawkes
3
,
Gavin Giovannoni
3
,
Michael Levy
4
,
Ann Yeh
5
Affiliations
1
The University of Newcastle, Australia; Hunter New England Health, Newcastle, Australia. Electronic address: Jeannette.lechner-scott@health.nsw.gov.au.
2
The University of Newcastle, Australia; Hunter New England Health, Newcastle, Australia.
3
Barts Health, London, United Kingdom.
4
Havards School of Medicine, Boston, USA.
5
Sickkids Research Institute, Toronto, Canada.
PMID:
35985058
PMCID:
PMC9364755
DOI:
10.1016/j.msard.2022.104102
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Multiple Sclerosis* / drug therapy
Vaccination
Vaccination Hesitancy
Vaccines*
Substances
Vaccines